Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 32 (November 10), 2007: pp. 5128-5132
Published by the American Society of Clinical Oncology
DOI: 10.1200/JCO.2007.12.6672

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minasian, L. M.
Right arrow Articles by Trimble, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minasian, L. M.
Right arrow Articles by Trimble, E. L.

REVIEW ARTICLE

Health-Related Quality of Life and Symptom Management Research Sponsored by the National Cancer Institute

Lori M. Minasian, Ann M. O'Mara, Bryce B. Reeve, Andrea M. Denicoff, Joseph Kelaghan, Julia H. Rowland, Edward L. Trimble

From the Divisions of Cancer Prevention, Cancer Control and Population Sciences, and Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD

Address reprint requests to Lori M. Minasian, MD, Community Oncology and Prevention Trials Research Group, 6130 Executive Blvd, MSC-7340, EPN, Rm 2016, Bethesda, MD 20892-7340; e-mail: minasilo{at}mail.nih.gov

For almost 30 years, the National Cancer Institute (NCI) has sponsored health-related quality-of-life (HRQOL) measures in cancer research as a means of including the patient's experience. The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations.

The workshop entitled "Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making" was supported by the Division of Cancer Prevention, the Division of Cancer Treatment and Diagnosis, and the Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, and by the American Cancer Society.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
JCOHome page
S. B. Clauser, P. A. Ganz, J. Lipscomb, and B. B. Reeve
Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making
J. Clin. Oncol., November 10, 2007; 25(32): 5049 - 5050.
[Full Text] [PDF]


Home page
JCOHome page
J. Lipscomb, B. B. Reeve, S. B. Clauser, J. S. Abrams, D. Watkins Bruner, L. B. Burke, A. M. Denicoff, P. A. Ganz, K. Gondek, L. M. Minasian, et al.
Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward
J. Clin. Oncol., November 10, 2007; 25(32): 5133 - 5140.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online